{
  "Cancer Histology Subtype (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3824, 
        3830
      ]
    }
  ], 
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2724, 
        2733
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2939, 
        2948
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3794, 
        3803
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6358, 
        6381
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2621, 
        2648
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6015, 
        6050
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2508, 
        2512
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2560, 
        2564
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2661, 
        2665
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2857, 
        2861
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3036, 
        3040
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3748, 
        3752
      ]
    }
  ], 
  "Lymphatic System Location (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2872, 
        2885
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        709, 
        738
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2457, 
        2483
      ]
    }
  ], 
  "Negative Findings Phraseology (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2915, 
        2948
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3074, 
        3098
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2928, 
        2938
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3777, 
        3785
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6131, 
        6141
      ]
    }
  ], 
  "Neoplasm Grade Value (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4297, 
        4298
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2513, 
        2519
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2653, 
        2659
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3028, 
        3034
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3786, 
        3793
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2485, 
        2487
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2557, 
        2559
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2589, 
        2591
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2650, 
        2652
      ]
    }, 
    {
      "__agreement__": "FALSE NEGATIVE", 
      "__annotator__": "Gemma", 
      "__extent": [
        2841, 
        2843
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3025, 
        3027
      ]
    }
  ], 
  "Synoptic Report Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3243, 
        3260
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PathSys|Associated Pathologists, LLC d/b/a PathGroup^44D0306984^CLIA|eMARCPlus|TN Cancer Registry|20170918000104||ORU^R01^ORU_R01|201709180001040001|P|2.5.1|TN||||||||VOL_V_40_ORU_R01-CCR1^NAACCR_CP\nOBR|1||17-SR-002709^PathSys^44D0306984^CLIA|11529-5^SURGICAL PATH REPORT^LN|||20170829000000|||||||20170829000000|&Breast, Exc. of Lesion, requiring micro. margins, Lymph Node, Biopsy, Breast, Exc. of Lesion, requiring micro. margins|1043299464^^^^^^MD^^CMS^D^^^NPI||||||20170908000000|||F||||||C50.912^Malignant neoplasm of unspecified site of left female breast^I10~N60.92^Unspecified benign mammary dysplasia of left breast^I10~R59.0^Localized enlarged lymph nodes^I10|1245210632&&&&&&&&CMS\n\n\n\n\n\n\n\nPath report.gross description\n\n1. Received in fixative labeled \"\" and designated on the requisition as \"needle localization left breast, short stitch superior, long stitch lateral\" is a 45 g piece of yellow-tan to pink lobulated adipose tissue (8.5 x 7.5 x 1.6 cm) with a 3.0 cm needle localization wire protruding from the superior aspect. The margins are inked as follows; superior blue, inferior green, medial yellow, lateral red, anterior orange, and posterior black. Serially sectioning the specimen reveals an apparent poorly circumscribed, poorly demarcated scarred area from a previous biopsy (0.5 x 0.5 cm) extending to the anterior margin. There is a gray-white area of dense fibroglandular tissue (2.0 x 1.3 cm) identified at the inferior margin. No definite residual tumor is identified. Representative sections are submitted as follows: 1A-1G, the entire scarred area to include the anterior, posterior, and superior margins, 1/1 each; 1H- 1N, the fibroglandular tissue to include the anterior, posterior, and inferior margins, 1/1 each; 1O, lateral margin, 1/1; 1P, medial margin, 1/1. 2. Received in fixative labeled \"\" and \"left axillary lymph nodes\" are 2 pink-tan lymph nodes with a small amount of attached adipose tissue (1.2 x 1.0 x 0.8 cm and 1.5 x 1.2 x 0.8 cm). The smaller node is trisected and submitted in cassette 2A, 3/1 and the larger node is sectioned and submitted in cassette 2B, 4/1. 3. Received in fixative labeled \"\" and \"additional inferior margin\" is a 2.5 x 2.5 x 1.3 cm piece of rubbery, yellow-tan lobulated adipose tissue. The external surface is marked with orange ink. Serially sectioning the specimen reveals no discrete lesions. The specimen is entirely submitted in cassettes 3A-3C, 2/1 each. (BKC)\n\n\nPath report.site of origin\n\n1. Needle localization left breast, stitch short superior, long lateral 2. Left axillary lymph nodes x2 3. Additional inferior margin\n\n\nPath report.final diagnosis\n\n1. Breast, left, needle localization lumpectomy:     Infiltrating mammary carcinoma (0.6 cm in greatest dimension), intermediate       nuclear grade.     Surgical margins negative for tumor. 2. Lymph nodes, left axillary, sentinel node biopsy:     Two lymph nodes, negative for metastatic carcinoma by H and E and controlled       CK AE1/AE3 immunohistochemical stain. (0/2) 3. Breast, left, additional inferior margin:     No malignancy identified.     Breast parenchyma with focally florid usual ductal hyperplasia, apocrine       metaplasia, and duct ectasia. AJCC Stage: pT1b (sn) pN0(i-) CANCER CHECKLIST: INVASIVE CARCINOMA OF THE BREAST: Complete Excision (Less Than Total Mastectomy, Including Specimens Designated Biopsy, Lumpectomy, Quadrantectomy, and Partial Mastectomy With or Without Axillary Contents) and Mastectomy (Total, Modified Radical, Radical With or Without Axillary Contents)Radical, Radical With or Without Axillary Contents) 2.006.001.1000043 SPECIMEN  Procedure: Excision with image-guided localization  Lymph Node Sampling: Sentinel lymph node(s)  Specimen Laterality: Left TUMOR  Histologic Type: Invasive mammary carcinoma of no special type (ductal, not otherwise specified)  Glandular (Acinar) / Tubular Differentiation: Score 3 (< 10% of tumor area forming glandular / tubular structures)  Nuclear Pleomorphism: Score 2 (Cells larger than normal with open vesicular nuclei, visible nucleoli, and moderate variability in both size and shape)  Mitotic Rate: Score 1 (<=3 mitoses per mm2)  Number of Mitoses per 10 High-Power Fields: 1mitotic figures  Diameter of Microscope Field (mm): 0.55mm  Overall Grade: Grade 2 (scores of 6 or 7)  Ductal Carcinoma In Situ (DCIS): No DCIS is present  Lobular Carcinoma In Situ (LCIS): Not identified  Tumor Size: Size of Largest Invasive Carcinoma: 6 mm  Tumor Focality: Single focus of invasive carcinoma Macroscopic and Microscopic Extent of Tumor  Skin: Skin is not present  Skeletal Muscle: No skeletal muscle is present Accessory Tumor Findings  Lymph-Vascular Invasion: Not identified  Dermal Lymph-Vascular Invasion: No skin present  Microcalcifications: Present in nonneoplastic tissue  Treatment Effect: Response to Presurgical (Neoadjuvant) Therapy: No known presurgical therapy MARGINS  Invasive Carcinoma: Margins uninvolved by invasive carcinoma  Distance from Closest Margin: 2mm  Closest Uninvolved Margin: Posterior  Ductal Carcinoma In Situ (DCIS): DCIS not present in specimen LYMPH NODES  Sentinel Node Status: Sentinel lymph node biopsy performed  Number of Sentinel Nodes Examined: 2  Method of Evaluation of Sentinel Lymph Node(s): H and E, multiple levels, Immunohistochemistry  Number of Lymph Node(s) Examined (sentinel and nonsentinel):  2  Lymph Node Involvement: None identified STAGE (pTNM)  Primary Tumor (Invasive Carcinoma) (pT): pT1b: Tumor > 5 mm but <= 10 mm in greatest dimension  Modifier: (sn): Only sentinel node(s) evaluated. If 6 or more nodes (sentinel or nonsentinel) are removed, this modifier should not be used.  Category (pN): pN0 (i-): No regional lymph node metastases histologically, negative IHC  Distant Metastasis (pM): Not applicable - pM cannot be determined from the submitted specimen(s) ADDITIONAL STUDIES (from previous biopsy 17-SR-2451) Estrogen receptor: positive Progesterone receptor: positive Her2 IHC: 3+ Her2 FISH: amplified\n\n\nPath report.microscopic examination\n\nMicroscopic examination is performed. 2. Controlled CK AE1/AE3 is negative for metastatic foci. 3. A controlled CK 5/6 immunohistochemical stain is performed to further asses the florid usual ductal hyperplasia. Staining is retained, confirming the presence of mixed cell types and the benign diagnosis.\n\n\nPath report.relevant Hx\n\nHistory - Left breast carcinoma; malignant neoplasm of unspecified site\n\n\n"
}